Translational Science Hub
World-Class Research in Queensland
The Translational Science Hub connects world-class researchers in Queensland with Sanofi scientists in France and the US, creating a first-of-its-kind, global scientific community focused on mRNA technology and translational science.
The Translational Science Hub is proudly supported by Sanofi, Griffith University, The University of Queensland and the Queensland Government.
Three key focus areas for the Translational Science Hub are to:
1. Optimise mRNA platform technology: This includes improving mRNA as a vaccine technology that can be used for multiple vaccine candidates and for therapeutics.
2. Advance the development of vaccine candidates: Influenza, RSV, Chlamydia and Acne are some of the vaccine candidates we are developing in Queensland.
3. Bring together the local academic and industry network: By having a R&D presence in Australia, Sanofi is able to work more closely with the local scientific talent and help create a strong and sustainable scientific ecosystem.
I’m delighted to work with our team at the Translational Science Hub. Located in Queensland, we are providing opportunities to scientists and researchers and helping talent remain in Australia. I’m particularly pleased to see female talent filling our senior roles which reflects Sanofi’s ambition to ensure women and men are represented equally among our senior leaders.
Dr Iris Depaz
Managing Director, Translational Science Hub
Our researchers are internationally recognised at developing new vaccines and therapies, while our Clinical Trial Unit is a leader in testing safety and efficacy. We look forward to the work we undertake here in Queensland with the aim of improving global health outcomes.
Professor Carolyn Evans
Vice Chancellor and President, Griffith University
We have invested in people and facilities to ensure mRNA for pre-clinical research can be developed and produced in Queensland. Collaboration and partnership are at the heart of all great research, and we look forward to making a difference to global health in collaboration with our partners.
Professor Deborah Terry
Vice Chancellor and President, The University of Queensland
Creating Research & Industry Jobs in Queensland
Research and industry jobs are being created in Queensland, including scientists, researchers and project managers. These professionals will be dedicated to improving mRNA technology for a range of diseases.
All potential candidates must either already live and work in Queensland or be prepared to relocate to Queensland. Recruitment is managed across the partners of the Translational Science Hub. Positions are advertised locally and on universities jobs pages when positions are open for applicants.
Growing the scientific ecosystem in Queensland
Thirteen highly skilled researchers and scientists are now employed by Sanofi in Queensland, with further growth expected in 2024.
The Translational Science Hub has recruited a Head and Deputy Head of Clinical Operations, two Global Clinical Development Strategy Experts, a Project Lead and Coordinator, plus Biostatisticians to explore next generation vaccines using mRNA technology. Dr Iris Depaz also moved into her new position as Managing Director of the Translational Science Hub.
New bases in Brisbane and Gold Coast
Sanofi officially opened research sites at Griffith University Gold Coast and the Translational Research Institute in Brisbane. Researchers will use university infrastructure and technology to better understand mRNA vaccine technology, which will help to optimise the platform to produce better vaccines and expand its use in the development of therapies to treat a variety of diseases.
Growing the scientific ecosystem in Queensland
A team of highly skilled researchers and scientists are now employed by Sanofi in Queensland, with further growth expected in the coming years.
Dr Iris Depaz has been appointed as the Managing Director of the Translational Science Hub. Also recruited are: our Head and Deputy Head of Clinical Operations, two Global Clinical Development Strategy Experts, a Project Lead and Coordinator, plus Biostatisticians to explore next generation vaccines using mRNA technology.